The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy-Reference-Cited by-同舟云学术

The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Published:2022-07 Issue:5 Volume:22 Page:424-438
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Jiang Cong^ORCID,Zhang Shiyuan,Qiao Kun,Xiu Yuting,Yu Xiao,Huang Yuanxi

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

3. Patterns of use of docetaxel-containing adjuvant chemotherapy among chinese patients with operable breast cancer: a multicenter observational study;Xie;Adv Ther,2019

4. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer;Franceschini;Ann Ital Chir,2018

5. Monitoring neoadjuvant chemotherapy for breast cancer by using three-dimensional subharmonic aided pressure estimation and imaging with US contrast agents: preliminary experience;Nam;Radiology,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of pro-inflammatory markers at the preoperative stage in Algerian women with breast cancer;Forum of Clinical Oncology;2024-06-18

2. Prognostic and clinicopathological value of systemic inflammation response index (SIRI) in patients with breast cancer: a meta-analysis;Annals of Medicine;2024-04-03

3. Peripheral blood inflammatory indexes in breast cancer: A review;Medicine;2023-12-01

4. Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis;BMJ Open;2023-11

5. A novel inflammation-related prognostic model for predicting the overall survival of primary central nervous system lymphoma: A real-world data analysis;Frontiers in Oncology;2023-03-28